ArticleJournal of experimental & clinical cancer research : CR2022

SOCS7/HuR/FOXM1 signaling axis inhibited high-grade serous ovarian carcinoma progression.

Yanhua Du et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.